My Market Wizard

GSK plc 6-K Analysis & Summary – 3/14/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

GSK plc

Filing date:

03/14/2025

TLDR:

GSK plc reports the acquisition of ordinary shares under the Company’s Share Reward Plan by multiple directors and key personnel on March 11, 2025.

ELI5:

Top executives at GSK are getting company shares as part of their compensation plan. This happened on March 11th, and each share was worth about £15.45.

Accession #:

0001654954-25-002793

Published on

Analyst Summary

  • Multiple PDMRs, including the CEO and CFO, acquired ordinary shares of GSK plc under the Company’s Share Reward Plan.
  • Each PDMR acquired 8 partnership shares and 8 matching shares.
  • The acquisition price was £15.4540 per share.
  • The transactions took place on 2025-03-11 at the London Stock Exchange (XLON).

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️